Purchase Order 75N95018P00377
- Not listed
- This is a federal contract award from the National Institute on Drug Abuse (NIDA), a civilian agency, to a sole proprietorship called Morrell Christopher H. The contract is a purchase order valued at $150,000.00 and was awarded on July 1, 2015 with a performance period ending on June 30, 2018. The contract is designated as a total small business set-aside. Based on the information provided, Morrell Christopher H appears to specialize in providing biostatistical analysis and data collaboration...
- This is a $255,000.00 firm-fixed-price purchase order awarded by the National Institute on Aging (NIA), part of the National Institutes of Health (NIH), to Morrell Christopher H, a sole proprietorship. The contract is for collaboration and statistical analyses of data from the NIA's Laboratory of Cardiovascular Science (LCS) and Translational Gerontology Branch (TGB) projects. This work focuses on cardiovascular science and translational gerontology research. The contract has a period of...
- This is a firm fixed price purchase order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency within the U.S. Department of Health and Human Services (HHS), to Deborah Colosi for $15,000.00. Under this contract, Dr. Colosi will develop several funding announcements for the National Institute of Mental Health's (NIMH) Division of Aging Research (DAR). The contract does not have a set-aside designation and was awarded on October 1, 2011, with a completion date of January...
- This is a firm fixed-price purchase order awarded to Paul C. Anderson, a medicinal chemistry consultant, to de-obligate unexpended and expiring Fiscal Year 2020 funding for the National Institute on Drug Abuse (NIDA), a civilian agency. The contract has a ceiling value of $342,435.00 and a completion date of February 27, 2023. It was awarded on February 28, 2018 and does not have a set-aside designation. This contract supports NIDA's administrative efforts to close out older fiscal year funds in...
- The federal contract award is for the National Institute on Drug Abuse (NIDA), a civilian agency of the U.S. government, to procure supplies from Med Associates, Inc., a for-profit, woman-owned manufacturer of scientific equipment and software. The $16,287.50 firm fixed price purchase order is to provide the laboratory members of NIDA researcher Leandro Vendruscolo with items needed to perform experiments involving alcohol and opioids in mice and rats. The contract does not have a set-aside...
- This is a firm fixed-price purchase order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency under the National Institutes of Health, to Med Associates, Inc., a for-profit, woman-owned small business manufacturer and supplier of specialized scientific laboratory equipment and software. The contract award, valued at $18,898.50, is for the delivery of products that support research into substance use disorders, neurological processes, addiction mechanisms, and behavioral...
- This is a $12,264.50 firm fixed price purchase order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency within the National Institutes of Health (NIH), to Med Associates, Inc. The contract is for the delivery of custom rat behavior box parts to support an ongoing NIDA research project that started prior to January 20, 2025. This award was not set aside and is not associated with a larger contract vehicle. As a prime contractor, Med Associates has previously provided...
- This is a $75,000.00 firm fixed price purchase order awarded by the National Institute on Drug Abuse (NIDA), which is part of the National Institutes of Health (NIH), a civilian agency, to Stellate Communications LLC, a woman-owned small business. The purpose of the contract is to provide scientific writing, figure design, and layout support to the National Institute of Mental Health (NIMH) Unit of Neurons, Circuits and Behavior (UNCB). The contract is not set aside and has an ultimate...
- This is a federal contract award issued by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH), to Curia Global Inc. (doing business as Amri). The contract is part of the Medicinal Chemistry Support Program for Therapeutic Development (MCSP) and has a task order number of NIH-NINDS-20-03. The contract is focused on "Medicinal Chemistry Support Program for Therapeutic Development" and specifically on the "BASE EC (PAIN)"...
- This is a $75,630.97 firm fixed-price purchase order awarded by the National Institute on Drug Abuse (NIDA), a component of the U.S. Department of Health and Human Services, to Clarivate Analytics (Us) LLC, a global leader in scientific and scholarly research information products and services. The contract is not designated as a set-aside. Clarivate Analytics was awarded this purchase order to provide scientific literature databases, analytics platforms, and program evaluation services to...
This $103,700.00 firm-fixed-price purchase order contract was awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Morrell Christopher H, a sole proprietorship. The contract is for "SPLIT CAN MORRELL" and has a period of performance ending on June 30, 2020. No set-aside designation was used for this award. Based on the information provided, Morrell Christopher H appears to specialize in providing biostatistical analysis and data collaboration services to the National Institutes of Health (NIH), specifically supporting projects within the National Institute on Aging's (NIA) Laboratory of Cardiovascular Science (LCS) and Translational Gerontology Branch (TGB). This contract is likely part of Morrell Christopher H's ongoing work providing statistical analysis and collaboration services related to cardiovascular science and translational gerontology research for the NIA.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00002 | Funding Only Action | $0 | 5/6/19 | |
| P00001 | Exercise an Option | $51.9k | 4/12/19 | |
| Not listed | Not listed | $51.9k | 6/25/18 |